| Intravitreal Bevacizumab Injection in Diabetic Papillopathy. |
|
Jin Hee Shin, Kyung Seek Choi |
|
Department of Ophthalmology, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Korea. ckseek@schmc.ac.kr |
| 유리체강내 베바시주맙 주입술을 이용한 당뇨병유두병증의 치료 1예 |
|
신진희⋅최경식 |
|
Department of Ophthalmology, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Korea |
|
|
| Abstract |
PURPOSE
To report a case where intravitreal bevacizumab injection was an effective treatment for diabetic papillopathy in a type 2 diabetic patient. CASE SUMMARY: A 47-year-old male with a 10-year history of diabetes mellitus type 2 presented to our clinic for evaluation of diabetic retinopathy. There were no subjective symptoms including blurred vision or visual defect, and best corrected visual acuity (BCVA) was 20/20 in the right eye and 20/30 in the left eye. Fundus examination showed hyperemic optic disc swelling with telangiectatic new vessels, and fluorescein angiography leakage from the optic disc with neovascularization. The patient underwent fractionated panretinal photocoagulation. Ten days later, he complained of painless blurred vision with significant optic nerve head swelling and BCVA was 20/80 in the left eye. Intravitreal bevacizumab injection was administered, optic disc swelling was significantly decreased and BCVA improved to 20/30 after two months. CONCLUSIONS: Diabetic papillopathy with severe decreased visual acuity can be treated with intravitreal bevacizumab injection. |
| Key Words:
Bevacizumab injection;Diabetic papillopathy |
|
PDF Links
Full text via DOI
Download Citation
